Subject matter experts from Regulatory Compliance Associates® Inc. discuss how too many organizations scramble when an FDA inspection occurs because they fail to be adequately prepared. True inspection preparedness, however, supplements internal audits with a practiced inspection process and focused behavioral training.
While internal audits are a key component of inspection preparedness, they tend to be informal, less intense, and more focused on auditing than inspecting. True inspection preparedness supplements internal audits with a practiced inspection process and focused behavioral training for key personnel.
Before a FDA inspection occurs, organizations should have an inspection process in place and conduct mock inspections. Like any process, inspection readiness needs a plan that is executed, assessed, and continuously improved upon.
Roles & Responsibilities
The Inspection Room (Front Room)
While inspectors often walk the facility, the inspection room provides a meeting space to review documentation and answer questions from the inspectors. In this “front room,” system owners or subject matter experts (SMEs) review and present materials to the FDA inspector.
The Control Room (Back Room)
The control room provides the documentation, interviewees, and preparation that is needed to support the inspection process. This “back room” team processes requests for information, retrieves documents from electronic systems, and also triages documents as needed. The control room is staffed with quality and technical personnel who log requests for information and alert department heads within the organization.
Control room personnel should always:
- Conduct a minimum of two reviews of every document prior to sending it to the inspection room:
- Quality Review:
- Make sure it points to valid SOPs and Work Instructions, etc.
- Technical Review:
- Make sure the SMEs have reviewed and are prepared to speak to the process with the inspector
- Have back-up printers, toner, copiers and paper on hand
Some organizations appoint runners to take the data back and forth between the control room and inspection room. There are technology solutions to operationalize the inspection process as well.
In the past, employees were often trained to give curt answers to FDA inspectors to avoid inadvertent revelations to the agency. This approach created fear and mistrust among employees, and set up adversarial relationships with FDA staff. In order to create the most beneficial inspection process environment, however, both the agency and the company need to form a partnership. Key behavioral tips for success include:
- Empower the inspection and control room teams.
- Bring SMEs into the control room to help gather data, review documents, and consult on the answer before they are summoned to the inspection room.
- Help SMEs understand their role in the bigger picture of the inspection. Prep them on related questions that have already been asked.
- Don’t allow an SME to bring in notes or an uncontrolled document.
- Use the control room to debrief SMEs after meetings with the inspector.
- Anticipate and prepare. The language used in inspector requests can provide insights. Anticipate next questions, proactively pull documents, and understand related metrics. For example, if the inspector asks about CAPA, review related documents such as open CAPAs, high-risk CAPAs, the average length of time for CAPAs, and the longest time for open CAPAs. Be prepared to answer the inspector’s next questions.
Practicing the inspection process, however, can be one of the best ways to help employees learn appropriate behaviors and response techniques. Train employees to:
- Focus on the question asked; restate the question when unsure of what’s being asked.
- Readily admit to not knowing an answer, but provide a date and time when the answer will be provided.
- Create an environment that reinforces the positive but recognizes weaknesses, such as “we understand this is an area for improvement,” rather than “this has been a problem for a long time.”
- Recognize the need for training across the organization on inspection readiness. Consider off-site locations as well. The FDA inspection process starts when the FDA inspector pulls up into the parking lot and interfaces with reception and security personnel. Don’t limit inspection training to just inspection and SME personnel.
Many companies conduct internal audits as part of their inspection readiness strategies. Mock inspections, however, take the next step and allow companies to actually practice the inspection room, the control room, and inspector interaction.
During mock inspections, organizations set up inspection rooms and control rooms to help teams learn how to readily access documentation that would potentially be requested during an inspection. Additionally, these practice sessions give employees an opportunity to demonstrate proper behavior and interviewing techniques when working with the regulatory agency.
A mock inspection can also be used to probe further on issues uncovered during internal audits. The mock Inspection team should bring in SMEs and other personnel as needed for this activity. This approach helps the organization fully understand areas needing improvement, and gives them a platform to take corrective action before the agency actually arrives.
Being properly prepared for inspection ensures that the inspection process will run smoother, decreases the likelihood of observations, and helps groom the organization and individuals for higher levels of future performance.
Published on Medical Device and Diagnostic Industry.
Regulatory Compliance Services
Increasingly, life science companies are feeling the pressure of greater scrutiny by regulators and responding by developing sustainable compliance strategies. Whether it’s preparing for an audit or developing a response to an FDA finding, Regulatory Compliance Associates® Inc. can help. Our subject matter experts are internationally known in the regulatory compliance consulting industry.
The regulations process surrounding pharmaceutical companies can be tricky for even the most experienced compliance veteran. If you’re consistently unable to comply with regulations, any notified body can deliver devastating consequences for your business. At RCA® Inc., we offer the pharmaceutical consultants and resources necessary to guide you in regulatory compliance.
We’re In Compliance
From family-owned enterprises to multinational Fortune 100 companies, we work with all types of pharmaceutical businesses. RCA® Inc. is a certified ISO 9001 organization: we understand navigating the changing demands of the FDA and other regulatory agencies.
Over 500 industry experts, FDA veterans and consulting professionals oversee our services to ensure that your business is protected to the fullest possible extent. Regulatory policy is what we do – and we do more of it than anyone we know.
RCA Compliance Services
We offer the following healthcare consulting compliance services:
The best thing you can do to avoid a compliance crisis is to take preventive measures that will locate and remedy any outstanding issues. At RCA® Inc., our FDA compliance consulting experts have decades of experience in both regulatory compliance program strategy and execution. We’ll help you measure your quality system with FDA regulations to assess any process weaknesses and opportunity to improve.
Our range of compliance regulatory services include:
- Quality Infrastructure
- PAI, Validation
- Facilities and Maintenance
- Laboratory (GLP)
- Process Assessments to Streamline and Optimize New and Existing Systems.
Periodic regulatory audits are necessary to both ensure the continued quality regulatory compliance of your organization. An internal audit helps maintain your readiness for an FDA inspection — and we have the resources to help. Our experienced team of ASQ-CQA and RABQSA certified auditors is available to perform a range of internal audit services, including:
- Contact Manufactures (CMO)
- Quality Systems
- Clinical (CRO) and Clinical Manufacturing
- Data Integrity
- 503A & 503B
- Combination Products
Regulatory Agency Response
Unfortunately, compliance crises do happen, and they can have a lasting impact on your business if you are unintentionally caught off guard. We can assist you in developing a customized response and plan of action to help remediate the effects of a FDA 483 warning. Our compliance and regulatory services team is here to provide the guidance you need most during this time, with response solutions for:
- FDA Form 483
- Warning Letter
- Consent Decree
- Import Bans
Preparation, Training, and Inspection Readiness
Sitting back and hoping for your next FDA inspection to go well isn’t an option — you need active preparation and training tailored to your needs and business goals. RCA® Inc. will help you thoroughly prepare for inspections with an extensive range of training programs, mock inspections and other readiness solutions, such as:
- Mock Inspections
- Back Room/ Front Room set-up and process
- Inspection Analysis & Report
- Response Letter Assistance
- Proof Book Development
- Business Relations (Leadership Development Training)
- Corporate Regulation Examples
- Regulatory Law
- Regulatory Board
- Legal Compliance
- Corporate Regulation Examples
- Industry Relations (Leadership Development Training)
- Types of Regulation
- Medical Regulations
- Security Regulations
- Cybersecurity Regulations
- Data Compliance Regulations
- Types of Regulation
Regulatory Compliance Associates® (RCA) provides regulatory compliance consulting to the following industries for resolution of life science challenges:
We understand the complexities of running a life science business and possess areas of expertise that include every facet of R&D, operations, regulatory affairs, quality, and manufacturing. We are used to working on the front lines and thriving in the scrutiny of FDA, Health Canada, MHRA and globally-regulated companies.
As your partners, we can negotiate the potential minefield of regulatory compliance and regulatory due diligence with insight, hindsight, and the clear advantage of our unique expertise and experience.
- Founded in 2000
- Headquartered in Wisconsin (USA)
- Expertise backed by over 500 industry subject matter experts
- Acquired by Sotera Health in 2021
About Sotera Health
The name Sotera Health was inspired by Soteria, the Greek goddess of safety, and reflects the Company’s unwavering commitment to its mission, Safeguarding Global Health®.
Sotera Health Company, along with its three best-in-class businesses – Sterigenics®, Nordion® and Nelson Labs®, is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. With a combined tenure across our businesses of nearly 200 years and our industry-recognized scientific and technological expertise, we help to ensure the safety of over 190 million patients and healthcare practitioners around the world every year.
We are a trusted partner to more than 5,800 customers in over 50 countries, including 40 of the top 50 medical device companies and 8 of the top 10 pharmaceutical companies.
To begin the Regulatory Compliance Associates® scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage.